In this group of patients, a rich CD20+ cell infiltration cannot be recognized as enough to secure tissues for cancer recurrence because the CD4+ cells are dysfunctional and are not able to induce the proper cytotoxicity of other cells. This evidence concerns the gene CD4 and cancer.